Cargando…

The Affordable Care Act’s Hospital Readmissions Reduction Program: Has the Biology Had Time to Catch Up With the Regulation?

Detalles Bibliográficos
Autores principales:	Mann, Douglas L., Tomaselli, Gordon F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	EDITOR'S PAGE
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113532/ https://www.ncbi.nlm.nih.gov/pubmed/30167551 http://dx.doi.org/10.1016/j.jacbts.2016.10.004

Ejemplares similares

The Tafamidis Drug Development Program: A Translational Triumph
por: Maurer, Mathew S., et al.
Publicado: (2018)

Synthetic Biology, Directed Evolution, and the Rational Design of New Cardiovascular Therapeutics: Are We There Yet?
por: Mann, Douglas L.
Publicado: (2023)

Introducing JACC: Basic to Translational Science: Why Now?
por: Mann, Douglas L., et al.
Publicado: (2016)

Spine Surgery has Always had Multi-Specialty Roots: Time for Nonoperative Spine Care to Catch up and Join the Club
por: Wiechert, Karsten, et al.
Publicado: (2022)

Catching up on the Clean Air Act.
por: McIntosh, H
Publicado: (1993)

A prediction model for COPD readmissions: catching up, catching our breath, and improving a national problem
por: Amalakuhan, Bravein, et al.
Publicado: (2012)

Cardiac Amyloidosis: The “Tipping Point” Has Been Reached
por: Witteles, Ronald, et al.
Publicado: (2021)

Are Academic Medical Centers Placing Translational Scientists on the Endangered Species List?: A Call for Climate Change to Preserve the Species
por: Mann, Douglas L.
Publicado: (2017)

The 2017 March for Science
por: Mann, Douglas L.
Publicado: (2017)

Truth and Truthiness in Translational Research
por: Mann, Douglas L.
Publicado: (2017)

Can President Trump’s (Second) Choice for the Secretary of the Department of Human Health and Services Make Translational Research Great Again?
por: Mann, Douglas L.
Publicado: (2018)

The Rising Cost of Developing Cardiovascular Therapies and Reproducibility in Translational Research: Do Not Blame It (All) on the Bench
por: Mann, Douglas L.
Publicado: (2017)

Fake News, Alternative Facts, and Things That Just Are Not True: Can Science Survive the Post-Truth Era?
por: Mann, Douglas L.
Publicado: (2018)

JACC: Basic to Translational Science: Quo Vadis?
por: Mann, Douglas L.
Publicado: (2016)

Can Mr. Trump Make Translational Research Great Again?: Three Ways in Which a Trump Presidency Can Affect Translational Research
por: Mann, Douglas L.
Publicado: (2017)

Deus Ex Machina: Why Mechanism Matters in Translational Research
por: Mann, Douglas L.
Publicado: (2017)

JACC: Basic to Translational Science: The End of the Beginning
por: Mann, Douglas L.
Publicado: (2019)

What Are the Off-Target Effects of Plan “S” For Translational Investigators?
por: Mann, Douglas L.
Publicado: (2019)

Q4 Vital Signs: Can Machine Learning Protect Patients From the Machinery of Modern Medicine?
por: Mann, Douglas L.
Publicado: (2019)

Scott Gottlieb’s Resignation as FDA Commissioner Is a Loss for Translational Medicine
por: Mann, Douglas L.
Publicado: (2019)

Why Do Medical Journals Exist in the 21st Century?: Some Thoughts on the Next 5 Years of JACC: Basic to Translational Science
por: Mann, Douglas L.
Publicado: (2020)

Warped Speed: How COVID-19 Transfected and Transformed Medical Journals
por: Mann, Douglas L.
Publicado: (2020)

SARS-CoV-2 and Bats: From Flight to Fighting COVID-19
por: Mann, Douglas L.
Publicado: (2020)

JACC: Basic to Translational Science and Preprint Servers: Accelerating the Pace of Translation
por: Mann, Douglas L.
Publicado: (2020)

Can One Person Make a Difference?: Remembering the Remarkable Life and Career of Alfred Bove
por: Mann, Douglas L.
Publicado: (2019)

Chinese Health Care Workers and COVID-19: For Whom the Bell Tolls
por: Mann, Douglas L.
Publicado: (2020)

What I Learned From the Impeachment Process: Confessions of a Translationalist
por: Mann, Douglas L.
Publicado: (2020)

Will COVID-19 Transform Translational Medicine?
por: Mann, Douglas L.
Publicado: (2020)

JACC: Basic to Translational Science 2020 Top Reviewers:: A Year to Remember
por: Mann, Douglas L.
Publicado: (2021)

Resurgence?
por: Mann, Douglas L.
Publicado: (2021)

The Thomas Force Young Investigator Award
por: Mann, Douglas L.
Publicado: (2021)

Fake It Till You Make It: What Every Translational Investigator Can Learn From the Rise and Fall of Theranos
por: Mann, Douglas L.
Publicado: (2022)

Will Artificial Intelligence Transform Translational Medicine: (Not So) Elementary, My Dear Watson
por: Mann, Douglas L.
Publicado: (2021)

Now That We Have an Effective Vaccine for COVID-19, Will It Also Inoculate Us Against the Virus of Indifference?
por: Mann, Douglas L.
Publicado: (2021)

Translational Science, Vaccines, and the Milk of Human Kindness
por: Mann, Douglas L.
Publicado: (2021)

The Sad Bells of Ukraine: Is There Hope for the Future?
por: Mann, Douglas L.
Publicado: (2022)

When Pigs Fly What Will the Future of Heart Failure Therapeutics Look Like?
por: Mann, Douglas L.
Publicado: (2022)

The Law of Holes: Why Do Translational Scientists Keep Digging?
por: Mann, Douglas L.
Publicado: (2022)

Will Gene Editing Orphanize Rare Diseases?
por: Mann, Douglas L.
Publicado: (2023)

JACC: Basic to Translational Science: The Apple That Falls Closely to the JACC Family Tree
por: Fuster, Valentin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bmonfjm9n5aa2ftgie26cokdoq